Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
GlobeNewswire
Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024
SCOTTSDALE, Ariz., March 18, 2024 (GLOBE..